TrialThe Lancet. Haematology2019

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.

Francesca Ferrua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.